Patent details
300769
Product Name:
Everolimus, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300769
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2269603
Status:
Refused Art. 10 of the EC Regulations
Application number:
300769
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)
Marketing Authorization
Marketing Authorization Number:
EU/1/09/001, 003, 004 en 006-010 (C(2012)5347)
Marketing Authorization Type:
EEA
Marketing Authorization Date:
25/07/2012
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
09/11/2015
First Marketing Authorization date:
25/07/2012
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/12/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
23/07/2020
Applicant/holder
From:
26/09/2018
Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
From:
26/09/2018
Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)
Historical Applicant/holder
From:
09/11/2015
To:
26/09/2018
Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
11/12/2015
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Licensee
Name:
Novartis Pharma B.V.
From:
10/05/2019
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
31/20
Publication date:
31/07/2020
Description:
Lapse or annulment
2
Bulletin Heading:
VRV
Journal edition number:
51/19
Publication date:
18/12/2019
Description:
Lapse or annulment
3
Bulletin Heading:
MED
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Other communications
4
Bulletin Heading:
CO
Journal edition number:
49/18
Publication date:
28/11/2018
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
SPC
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Licence
Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201900908A
Date Registered:
10/05/2019
License Effective Date:
10/05/2018
License Expiration Date:
Scope of License:
Not Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Netherlands (NL)
Updated License Number:
Terminated License Number:
Added Licensee(s)
Name:
Novartis Pharma B.V.
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801726A
Date Registered:
26/09/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
1
Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
2
Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Filing date
Document type
Document Description
Number of pages
File Type
23/07/2020
Outgoing Correspondence
Decision refusal
2
PDF
/5/7/3/9/1/0800019375/docs/300769_13_355800l527a.pdf
14/04/2020
Outgoing Correspondence
Letter to applicant
1
PDF
/5/7/3/9/1/0800019375/docs/300769_9_338568l173.pdf
26/09/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/5/7/3/9/1/0800019375/docs/300769_6_outgoingcorrespondence20160926021041410.pdf
20/09/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/5/7/3/9/1/0800019375/docs/300769_5_incomingcorrespondencepaper20160921033609233.pdf
28/06/2016
Outgoing Correspondence
Outgoing Letter
1
PDF
/5/7/3/9/1/0800019375/docs/300769_0_outgoingcorrespondence20160628110453134.pdf
21/06/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/5/7/3/9/1/0800019375/docs/300769_11_incomingcorrespondencepaper20160627035853248.pdf
23/03/2016
Outgoing Correspondence
Letter to applicant
3
PDF
/5/7/3/9/1/0800019375/docs/300769_3_outgoingcorrespondence20160325101841213.pdf
11/12/2015
Outgoing Correspondence
Outgoing Letter
1
PDF
/5/7/3/9/1/0800019375/docs/300769_12_21596l174.pdf
24/11/2015
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/5/7/3/9/1/0800019375/docs/300769_14_incomingcorrespondencepaper20151211025534257.pdf
09/11/2015
SPC Documents
Summary of the characteristics of the product
37
PDF
/5/7/3/9/1/0800019375/docs/300769_1_supplprotectioncertificate20210330034151848.pdf
09/11/2015
SPC Documents
Annex SPC
17
PDF
/5/7/3/9/1/0800019375/docs/300769_2_supplprotectioncertificate20210330034152019.pdf
09/11/2015
SPC Documents
Annex SPC
3
PDF
/5/7/3/9/1/0800019375/docs/300769_4_supplprotectioncertificate20210330034151930.pdf
09/11/2015
SPC Documents
Annex SPC
8
PDF
/5/7/3/9/1/0800019375/docs/300769_7_supplprotectioncertificate20200409104903310.pdf
09/11/2015
SPC Documents
Marketing Authorization SPC
4
PDF
/5/7/3/9/1/0800019375/docs/300769_8_supplprotectioncertificate20200409105057471.pdf
09/11/2015
Application Form
First filed application form
2
PDF
/5/7/3/9/1/0800019375/docs/300769_10_applicationform20151210123154955.pdf
09/11/2015
SPC Documents
Annex SPC
2
PDF
/5/7/3/9/1/0800019375/docs/300769_15_supplprotectioncertificate20200409104531471.pdf
09/11/2015
SPC Documents
Accompanying letter SPC
3
PDF
/5/7/3/9/1/0800019375/docs/300769_16_supplprotectioncertificate20210330032908270.pdf